Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Jonathan Strosberg
ResearcherPublications, citations & collaboration network
Jonathan Strosberg is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 430 works, 21,892 citations, an h-index of 70 and an i10-index of 196.
430
Works
21,892
Citations
70
h-index
196
i10-index
How has Jonathan Strosberg's publication output changed over time?
ScholarIQpublication output · 2010–2021
Output declined50% over the shown period — from 2 works in 2010 to 1 in 2021.
2
1
1
4
3
1
201020132015201720182021
What are the most-cited papers on Jonathan Strosberg?
ScholarIQmost cited works
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning
New England Journal of Medicine. 20173,241 CitationsOPEN ACCESS
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao, Nicola Fazio, Simron Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiří Tomášek, Markus Raderer, Harald Lahner, Maurizio Voi, Lida Pacaud, Nicolas Rouyrre, Carolin Sachs, Juan W. Valle, Gianfranco Delle Fave, Eric Van Cutsem, Margot Tesselaar, Yasuhiro Shimada, Do‐Youn Oh, Jonathan Strosberg, Matthew H. Kulke, Marianne Pavel
The Lancet. 20151,272 Citations
First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
Jonathan Strosberg, Robert L. Fine, Junsung Choi, Aejaz Nasir, Domenico Coppola, Dung‐Tsa Chen, James F. Helm, Larry K. Kvols
Cancer. 2010767 CitationsOPEN ACCESS
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H. Shah, Whitney Goldner, Al B. Benson, Emily K. Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, J.K.C. Chan, Satya Das, Paxton V. Dickson, Paul T. Fanta, Thomas J. Giordano, Þorvarður R. Hálfdánarson, Daniel M. Halperin, Jin He, Anthony P. Heaney, Martin J. Heslin, Fouad Kandeel, Arash Kardan, Sajid Khan, Boris W. Kuvshinoff, Christopher H. Lieu, Kimberly D. Miller, Venu G. Pillarisetty, Diane Reidy‐Lagunes, Sarimar Agosto Salgado, Shagufta Shaheen, Heloisa P. Soares, Michael C. Soulen, Jonathan Strosberg, Craig Sussman, Nikolaos A. Trikalinos, N. Uboha, Namrata Vijayvergia, Terence Z. Wong, Beth Lynn, Cindy Hochstetler
Journal of the National Comprehensive Cancer Network. 2021612 Citations
Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Jonathan Strosberg
S126094547. 2018611 CitationsOPEN ACCESS
Related on ScholarIQ
Moffitt Cancer Center
Institution
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Paper
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
Paper
First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
Paper
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Paper
Gastroenteropancreatic Neuroendocrine Tumors
Paper